KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Debt to Equity (2018 - 2025)

Historic Debt to Equity for ClearPoint Neuro (CLPT) over the last 12 years, with Q3 2025 value amounting to $1.84.

  • ClearPoint Neuro's Debt to Equity changed N/A to $1.84 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.84, marking a year-over-year change of. This contributed to the annual value of $0.47 for FY2023, which is 7520.33% up from last year.
  • Per ClearPoint Neuro's latest filing, its Debt to Equity stood at $1.84 for Q3 2025.
  • ClearPoint Neuro's 5-year Debt to Equity high stood at $1.84 for Q3 2025, and its period low was $0.2 during Q4 2021.
  • Its 4-year average for Debt to Equity is $0.53, with a median of $0.36 in 2023.
  • In the last 5 years, ClearPoint Neuro's Debt to Equity tumbled by 9774.75% in 2021 and then surged by 7520.33% in 2023.
  • Quarter analysis of 4 years shows ClearPoint Neuro's Debt to Equity stood at $0.2 in 2021, then surged by 33.0% to $0.27 in 2022, then surged by 75.2% to $0.47 in 2023, then surged by 291.51% to $1.84 in 2025.
  • Its Debt to Equity stands at $1.84 for Q3 2025, versus $1.46 for Q2 2025 and $0.47 for Q4 2023.